Theriva Biologics, Inc.
Theriva Biologics, Inc. scores highest on Price (89) and lowest on Nitro (28). Its PosiPenta is 45.24 out of 100, around the middle of similar companies.
On the Penta Grid this week, Theriva Biologics, Inc. is Grid #377 of 837 in the Healthcare sector in United States, and Grid #2,391 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Theriva Biologics, Inc. | 45.24 | 89 | 43 | 28 | 33 | 32 |
| Tempest Therapeutics, Inc. | 18.60 | 0 | 42 | 5 | 9 | 37 |
| Alaunos Therapeutics, Inc. | 40.95 | 6 | 50 | 65 | 52 | 32 |
| NeuroOne Medical Technologies Corporation | 37.95 | 26 | 58 | 11 | 41 | 53 |
| American Shared Hospital Services | 55.17 | 47 | 81 | 42 | 46 | 60 |
| Aethlon Medical, Inc. | 33.25 | 31 | 41 | 29 | 37 | 28 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 0.28 |
| P/B ratio | 0.78 |
EEarnings
| Trailing EPS | ₹69.14 |
| Forward EPS | ₹-18.94 |
NNitro
| Price | 19.69 |
| 52-week high | 80.51 |
| 52-week low | 15.15 |
| Fall from 52-week high | 75.5% |
TTorque
| Return on equity (ROE) | -101.87% |
| Debt-to-equity | 0.29 |
AAnchor
| Beta (price swings) | 1.19 |
| Market cap | ₹90 Cr |
| Insider holding | 1.63% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Theriva Biologics, Inc.'s PosiPenta score?
Theriva Biologics, Inc.'s PosiPenta is 45.24 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Theriva Biologics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Theriva Biologics, Inc. is Grid #377 of 837 in the Healthcare sector in United States, and Grid #2,391 of 4,000 in United States.
Which PosiPenta pillar is strongest for Theriva Biologics, Inc.?
Price (valuation), with a score of 89 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Theriva Biologics, Inc.?
Nitro (momentum), with a score of 28 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.